CAS No. |
1652561-87-9 |
|---|---|
中文名称 |
(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-乙酰氨基-1-氨基-12,15-二苄基-21-((S)-仲丁基)-9-(3-胍基丙基)-1-亚氨基-7,10,13,16,19-五氧代-2,8,11,14,17,20-六氮杂二十二酰氨基)-8-(2-氨基-2-氧代乙基)-5-((R)-1-羟基乙基)-2-异丁基-11,20-二甲基-3,6,9,21-四氧代-1,4,7,10-四氮杂环二十一碳-15-烯-11-基)-21-(2-氨基-2-氧代乙基)-6-(4-氨基丁基)-12,15-双(2-羧基乙基)-9-((R)-1-羟基乙基)-3-异丁基-1,4,7,10,13,16,19-七氧代-2,5,8,11,14,17,20-七氮杂二十二烷-22-酸 |
英文名称 |
(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-Acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosanamido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid |
别名 |
SAH-SOS1A |
标准英文名 |
(3S,6S,9S,12S,15S,21S)-1-((2S,5S,8S,11S,20S)-20-((6S,9S,12S,15S,21S)-6-acetamido-1-amino-12,15-dibenzyl-21-((S)-sec-butyl)-9-(3-guanidinopropyl)-1-imino-7,10,13,16,19-pentaoxo-2,8,11,14,17,20-hexaazadocosan-22-amido)-8-(2-amino-2-oxoethyl)-5-((R)-1-hydroxyethyl)-2-isobutyl-11,20-dimethyl-3,6,9,21-tetraoxo-1,4,7,10-tetraazacyclohenicos-15-en-11-yl)-21-(2-amino-2-oxoethyl)-6-(4-aminobutyl)-12,15-bis(2-carboxyethyl)-9-((R)-1-hydroxyethyl)-3-isobutyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosan-22-oic acid |
分子式 |
C100H159N27O28 |
分子量 |
2187.53 |
精确分子量 |
2186.18 |
SMILES |
[C@H](CC1=CC=CC=C1)(C(N[C@@H](CC2=CC=CC=C2)C(NCC(N[C@H](C(N[C@]3(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@]([C@@H](C)O)(C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@@H](CC(N)=O)C(O)=O)=O)=O)CCC(O)=O)=O)CCC(O)=O)=O)[C@@H](C)O)=O)CCCCN)=O)CC(C)C)=O)(C)CCCC=CCCC3)[H])=O)[C@H](CC)C)=O)=O)=O)NC([C@@H](NC([C@H](CCCNC(=N)N)NC(C)=O)=O)CCCNC(=N)N)=O |
标准SMILES |
CC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@]1(C)CCCC=CCCC[C@](C)(NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC1=O)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O |
用途 |
SAH-SOS1A is used as a peptide-based inhibitor of the SOS1/KRAS protein-protein interaction; it directly and independently blocks nucleotide binding to both wild-type and mutant KRAS (G12D, G12V, G12C, G12S, and Q61H), impairs KRAS-driven cancer cell viability, and inhibits the downstream ERK-MAPK phosphorylation signaling cascade. |
InChIKey |
IVWNCFWBZZQNEM-MTMGHKARSA-N |
|
|
评论 |
|---|